Cormorant Asset Management, LP

Position in TNGX — Tango Therapeutics, Inc.

CIK 1583977 BOSTON, MA

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$40,638,000

+$10,827,000 QoQ

Shares Held

1,300,000

-8.8% QoQ

Ownership

0.771%

of shares outstanding

% of Portfolio

2.06%

of 13F equity value

Holder Rank

#35

of 247 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. TNGX ranks #16 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	640,000	$214,265,600
2	BBOT	BridgeBio Oncology Therapeutics, Inc.	17,878,594	$136,234,886
3	PBLS	Parabilis Medicines, Inc.	4,615,612	$126,329,300
4	RAPP	Rapport Therapeutics, Inc.	2,657,521	$110,738,900
5	ERAS	Erasca, Inc.	6,000,000	$109,920,000
6	EWTX	Edgewise Therapeutics, Inc.	2,510,000	$101,981,300
7	EYPT	EyePoint, Inc.	7,000,000	$100,100,000
8	ALMS	Alumis Inc.	3,285,596	$92,456,671

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,638,000	1,300,000	-8.8%	Shares	Defined	2026-08-14
2026-03-31	$29,811,000	1,425,000	-65.4%	Shares	Defined	2026-05-15
2023-03-31	$16,261,948	4,116,949	0.0%	Shares	Defined	2023-05-15
2022-12-31	$29,847,880	4,116,949	0.0%	Shares	Defined	2023-02-14
2022-09-30	$14,903,355	4,116,949	-8.7%	Shares	Defined	2022-11-14
2022-06-30	$20,420,528	4,507,843	-8.0%	Shares	Defined	2022-08-15
2022-03-31	$37,135,822	4,899,185	0.0%	Shares	Defined	2022-05-16
2021-12-31	$53,597,083	4,899,185	+25.6%	Shares	Defined	2022-02-14
2021-09-30	$50,416,462	3,899,185	—	Shares	Defined	2021-11-15
2021-06-30 BCTG	—	800,000	0.0%	Shares	Defined	2021-08-16
2021-03-31 BCTG	—	800,000	0.0%	Shares	Defined	2021-05-17
2020-12-31 BCTG	—	800,000	0.0%	Shares	Defined	2021-02-16
2020-09-30 BCTG	—	800,000	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.